跳至主要内容
临床试验/NCT04447534
NCT04447534已完成3 期

Does Zinc Supplementation Enhance the Clinical Efficacy of Chloroquine/Hydroxychloroquine in Treatment of COVID-19?

Tanta University1 个研究点 分布在 1 个国家目标入组 191 人开始时间: 2020年6月23日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
状态
已完成
入组人数
191
试验地点
1
主要终点
Number of patients with improvement or mortality

研究概览

简要总结

we want to investigate if zinc supplementation enhance the clinical efficacy of chloroquine in treatment of COVID-19.

详细描述

we want to investigate if zinc supplementation enhance the clinical efficacy of chloroquine in treatment of COVID-19. As, zinc may be of value in these cases and may be of value in enhancing chloroquine effect.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Care Provider)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with positive COVID-19.

排除标准

  • Contraindications or hypersensitivity to chloroquine.

研究组 & 干预措施

Chloroquine or hydroxychloroquine

Experimental

Chloroquine or hydroxychloroquine alone

干预措施: Chloroquine or hydroxychloroquine (Drug)

Chloroquine or hydroxychloroquine with zinc

Experimental

Chloroquine or hydroxychloroquine with zinc

干预措施: Chloroquine or hydroxychloroquine (Drug)

Chloroquine or hydroxychloroquine with zinc

Experimental

Chloroquine or hydroxychloroquine with zinc

干预措施: zinc (Drug)

结局指标

主要结局

Number of patients with improvement or mortality

时间窗: 2 weeks

The number of patients with improvement or mortality.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Sherief Abd-Elsalam

Ass. Prof. Tropical Medicine

Tanta University

研究点 (1)

Loading locations...

相似试验